In Vivo Evidence in the Brain for Lithium Inhibition of Glycogen Synthase Kinase-3
Todd D. Gould(University of Maryland, Baltimore), Husseini K. Manji(National Institute of Mental Health)
Cited by 216
Related Papers
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
|Pharmacological Reviews|2018|1.2k
Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder
|Neuropsychopharmacology|2007|247
β-Catenin Overexpression in the Mouse Brain Phenocopies Lithium-Sensitive Behaviors
|Neuropsychopharmacology|2007|137
Experimenters’ sex modulates mouse behaviors and neural responses to ketamine via corticotropin releasing factor
|Nature Neuroscience|2022|133
NMDA Receptor Activation-Dependent Antidepressant-Relevant Behavioral and Synaptic Actions of Ketamine
|Journal of Neuroscience|2023|104